Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
Hepatology International, 06/26/09
Liaw YF et al. - Early induction of HBeAg seroconversion with interferon-based therapy or oral nucleos(t)ide analogues has important clinical and socioeconomic implications for the management of CHB.
Related Articles
Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09
Relevance Score: 83%
Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09
Relevance Score: 82%
Impact of Routine Hepatitis B Immunization on the Prevalence of Chronic Hepatitis B Virus Infection in the Marshall Islands and the Federated States of Micronesia
The Pediatric Infectious Disease Journal, 10/27/09
Relevance Score: 82%
Therapeutic vaccination and novel strategies to treat chronic HBV infection
Expert Review of Gastroenterology & Hepatology, 10/16/09
Relevance Score: 82%
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
Hepatology, 11/18/09
Relevance Score: 81%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Atazanavir-Associated Choledocholithiasis Leading to Acute Hepatitis in an HIV-Infected Adult
Annals of Pharmacotherapy, 12/03/09
Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy
Liver Transplantation, 12/03/09
Duration of hepatitis E viremia in pregnancy
International Journal of Gynecology & Obstetrics, 12/02/09
Article Search
Sponsor


See Latest Articles


